Атеротромбоз is a peer-reviewed russian-language open-access journal published by Remedium Group LTD in Russian Federation, operating under an open-access model since 2013. The journal covers Internal medicine.
Authors publish in Атеротромбоз without paying any article processing charge (APC) — making it a fully diamond/platinum open-access venue, supported entirely by its publisher or sponsor. Articles are released under the CC BY-NC-ND license (see other journals using this license).
Keywords
atherosclerosis, acute coronary syndrome, acute cerebrovascular disorder, antithrombotic therapy, anticoagulants
At a glance
- Publisher
- Remedium Group LTD
- Country
- Russian Federation
- Primary language
- Russian
- License
- CC BY-NC-ND
- Peer review
- Anonymous peer review
- OA since
- 2013
ISSN
- 2307-1109
- electronic
- 2658-5952
Frequently asked questions
Is Атеротромбоз peer-reviewed?
Yes — Атеротромбоз operates a Anonymous peer review review process.
Does Атеротромбоз charge an article processing charge (APC)?
No. Атеротромбоз does not charge any APC. Publication is free for accepted authors.
What subjects does Атеротромбоз publish?
Атеротромбоз publishes research in Internal medicine.
What languages does Атеротромбоз accept?
Атеротромбоз accepts manuscripts in Russian.
What is the ISSN of Атеротромбоз?
ISSN:
2307-1109 (print) · 2658-5952 (electronic).How do I submit a manuscript to Атеротромбоз?
Submit through the journal's official portal: visit submission page →